Virtual Patients...Real Results

Entelos is a life sciences company improving human health through predictive biosimulation. Using in silico disease models and a virtual patient approach, Entelos identifies and validates targets, develops biomarkers, improves the success rates of clinical trials, and helps bring therapeutics to market faster.
News Releases  » Media Coverage  » Events  »
Entelos Granted Patent for Innovative Diagnostic Capability in Obesity, Diabetes -
February  2, 2010

Visit Realab™, Entelos' online simulation tool.
Entelos featured in “The Knowledge Revolution” - PharmaVoice, Digital Edition, September 2009
Today Show interview with author David Ewing Duncan features "The Entelos Prognosis" - Today Show (NBC), March 11, 2009
FDA to Use Simulation Technology for Drug Testing - Wall Street Journal, December 16, 2008
See how Entelos technology is used to make personal health decisions.
Visit www.MyDigitalHealth.com.
SOT 2010: 49th Annual Meeting & ToxExpo - Salt Lake City, UT,
March 7-11
SBMC 2010 (Systems Biology of Mammalian Cells) - Frieberg, Germany,
June 3-5
For information on Entelos toxicogenomics solutions including DrugMatrix® and ToxFX™, please visit the Iconix website.
Copyright© 2009 Entelos, Inc. All rights reserved Disclaimer (U.S. Visitors)